Smith & Nephew Advanced Wound Management Appoints David Hoffman to Lead Business Development
HULL, England, and LARGO, Fla. -- Smith & Nephew's Advanced Wound Management division announces the appointment of David Hoffman as senior vice president of business development and strategic planning.
Hoffman joins Smith & Nephew from Boston Scientific Corporation where he has worked for 10 years most recently in their Endosurgery Group where he has been leading their new market development and strategic planning activity. Prior to his time with BSC he worked for Baxter Healthcare primarily in sales and international marketing roles.
"David has worked in the medical device industry for over 20 years in areas such as endoscopy, vascular, surgery and hospital supply. In that time he has gained a broad range of experience in strategic planning, business development, global marketing, market development for emerging technologies and sales management. He will be a valuable asset to Smith & Nephew," commented Joe Woody, president of advanced wound management.
Hoffman holds a BS in economics from Northwestern University and an MBA from Butler University. He resides in Concord, Mass. with his wife and children.
Â
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
